TM划分翻译段落小感

TM划分翻译段落小感

例如：

按 TM 自动分隔：

Global sales of REMICADE (infliximab) and SIMPONI (golimumab), treatments for inflammatory diseases, for the full year of 2011 increased 4 percent and declined 24 percent for the fourth quarter.  In territories retained, the combined sales of REMICADE and SIMPONI grew 21 percent for the full year and 8 percent for the fourth quarter of 2011.

In July 2011, the company transferred exclusive marketing rights for REMICADE and SIMPONI to Johnson & Johnson in Canada, Central and South America, the Middle East, Africa and Asia Pacific.  Merck retained exclusive marketing rights in Europe, Russia and Turkey.

治疗炎症性疾病的Remicade（英利昔单抗）和SIMPONI（戈利木单抗）的全球销售量2011年全年增长4％，第四季度下降24％。在其他药物方面，REMICADE与SIMPONI的总销售额在2011年第四季度和全年分别增长21％和8％。 2011年7月，公司将REMICADE与SIMPONI在加拿大、中南美洲、中东、非洲和亚太地区的独家销售权转让至强生公司。默克公司（Merck）保留在欧洲、俄罗斯和土耳其的独家销售权。

个人感受：像这样段落在用 TM 翻译时如果不切开，容易导致以下几点

1 翻译时浏览原文造成多次回看和视觉冗余，看多了极容易造成视觉疲劳，影响工作效率及准确性。

2 编辑接手时面临同样的问题，接下来的校对也一样。

3 易造成漏译、词句重复、标点误用。

4 单句分开的好处：“句子重复”比“段落重复”的概率较高，TM 更容易自动搜索到有效句段。

解决：

step1   切开 Global sales of REMICADE (infliximab) and SIMPONI (golimumab), treatments for inflammatory diseases, for the full year of 2011 increased 4 percent and declined 24 percent for the fourth quarter. 回车 In territories retained, the combined sales of REMICADE and SIMPONI grew 21 percent for the full year and 8 percent for the fourth quarter of 2011.

step2    变成这样 Global sales of REMICADE (infliximab) and SIMPONI (golimumab), treatments for inflammatory diseases, for the full year of 2011 increased 4 percent and declined 24 percent for the fourth quarter.

In territories retained, the combined sales of REMICADE and SIMPONI grew 21 percent for the full year and 8 percent for the fourth quarter of 2011.

step3   翻译 Global sales of REMICADE (infliximab) and SIMPONI (golimumab), treatments for inflammatory diseases, for the full year of 2011 increased 4 percent and declined 24 percent for the fourth quarter.  治疗炎症性疾病的Remicade（英利昔单抗）和SIMPONI（戈利木单抗）的全球销售量2011年全年增长4％，第四季度下降24％。在其他药物方面，REMICADE与SIMPONI的总销售额在2011年第四季度和全年分别增长21％和8％。

In territories retained, the combined sales of REMICADE and SIMPONI grew 21 percent for the full year and 8 percent for the fourth quarter of 2011.

step 4 还原段落

Global sales of REMICADE (infliximab) and SIMPONI (golimumab), treatments for inflammatory diseases, for the full year of 2011 increased 4 percent and declined 24 percent for the fourth quarter.  治疗炎症性疾病的Remicade（英利昔单抗）和SIMPONI（戈利木单抗）的全球销售量2011年全年增长4％，第四季度下降24％。在其他药物方面，REMICADE与SIMPONI的总销售额在2011年第四季度和全年分别增长21％和8％。In territories retained, the combined sales of REMICADE and SIMPONI grew 21 percent for the full year and 8 percent for the fourth quarter of 2011.

step 5 继续下一句翻译